These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2464591)

  • 1. Epitopes on the major capsid protein of simian virus 40.
    Babé LM; Brew K; Matsuura SE; Scott WA
    J Biol Chem; 1989 Feb; 264(5):2665-71. PubMed ID: 2464591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.
    Sato H; Hirata J; Furukawa M; Kuroda N; Shiraki H; Maeda Y; Okochi K
    J Virol; 1991 Apr; 65(4):1667-72. PubMed ID: 1705987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions.
    Bloom ME; Martin DA; Oie KL; Huhtanen ME; Costello F; Wolfinbarger JB; Hayes SF; Agbandje-McKenna M
    J Virol; 1997 Jan; 71(1):705-14. PubMed ID: 8985402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.
    Randhawa P; Viscidi R; Carter JJ; Galloway DA; Culp TD; Huang C; Ramaswami B; Christensen ND
    J Gen Virol; 2009 Mar; 90(Pt 3):634-639. PubMed ID: 19218208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against different epitopes of a 40 Kd capsid protein of infectious bursal disease viruses.
    Lee LH
    Proc Natl Sci Counc Repub China B; 1990 Apr; 14(2):75-84. PubMed ID: 1701058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.
    Robertson BH; Morgan DO; Moore DM
    Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
    Saiz JC; Gonzalez MJ; Borca MV; Sobrino F; Moore DM
    J Virol; 1991 May; 65(5):2518-24. PubMed ID: 1707983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
    Saikawa T; Anderson S; Momoeda M; Kajigaya S; Young NS
    J Virol; 1993 Jun; 67(6):3004-9. PubMed ID: 7684458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of two immunodominant antigenic epitopes conserved among the major inner capsid protein, VP7 of five bluetongue viruses.
    Li JK; Yang YY
    Virology; 1990 Oct; 178(2):552-9. PubMed ID: 2171194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.
    Zhou YJ; Burns JW; Morita Y; Tanaka T; Estes MK
    J Virol; 1994 Jun; 68(6):3955-64. PubMed ID: 7514681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus.
    Moore DM; Vakharia VN; Morgan DO
    Virus Res; 1989 Dec; 14(4):281-95. PubMed ID: 2483013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species- and genus-specific antigenic determinants of simian agent 12 VP1 as defined with monoclonal antibodies.
    Benton CV; Gilden RV; Shah KV
    Virology; 1982 Mar; 117(2):490-5. PubMed ID: 6175092
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
    Schofield DJ; Glamann J; Emerson SU; Purcell RH
    J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.
    Fender P; Kidd AH; Brebant R; Oberg M; Drouet E; Chroboczek J
    Virology; 1995 Dec; 214(1):110-7. PubMed ID: 8525605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common structural antigen of papovaviruses of the simian virus 40-polyoma subgroup.
    Shah KV; Ozer HL; Ghazey HN; Kelly TJ
    J Virol; 1977 Jan; 21(1):179-86. PubMed ID: 64625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of neutralizing epitopes on foot-and-mouth disease virus.
    Pfaff E; Thiel HJ; Beck E; Strohmaier K; Schaller H
    J Virol; 1988 Jun; 62(6):2033-40. PubMed ID: 2835507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding site of neutralizing monoclonal antibodies obtained after in vivo priming with purified VP1 of poliovirus type 1 is located between amino acid residues 93 and 104 of VP1.
    Wiegers KJ; Dernick R
    Virology; 1987 Mar; 157(1):248-51. PubMed ID: 2435056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.
    Crowther JR; Rowe CA; Butcher R
    Epidemiol Infect; 1993 Oct; 111(2):391-406. PubMed ID: 7691630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.